Status:
TERMINATED
The Decline in Walking Performance in Adults With Cerebral Palsy - Influence of Performance Fatigability
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Muscle Spasticity
Paralysis; Cerebral
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Due to an early brain injury occurring in antenatal or postnatal, cerebral palsy (CP) causes alteration in motor function with posture and gait disorders. It is commonly observed motor performance deg...
Detailed Description
One of the hypotheses to explain the decline in walking capacities in adults with CP is their greater fatigability, that could be related to energy overconsumption (due to the specific biomechanical c...
Eligibility Criteria
Inclusion
- Common for CP and healthy volunteers:
- Capable of walking for six minutes without stopping
- Capable of consenting to the tests
- Specific for the CP group
- GMFCS I or II at age 18
- Spastic diplegic cerebral palsy
Exclusion
- Counter-indications to the test procedures
- Mental retardation or intelligence quotient (IQ) below 80
- Accompanying diseases not allowing for the test setup
- Major surgeries altering performance in the last six months
- Injection of botulin altering maximal force production in the last three months
- Refusing to sign the consent form
Key Trial Info
Start Date :
May 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06163950
Start Date
May 2 2023
End Date
July 10 2024
Last Update
October 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Etienne
Saint-Etienne, France, 42055